Long-Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma.
Shin KI, Yoon MS, Kim JH, Jang WJ, Leem G, Jo JH, Chung MJ, Park JY, Park SW, Hwang HK, Kang CM, Kim SS, Park MS, Lee HS, Bang S.
Shin KI, et al. Among authors: lee hs.
Cancer Med. 2024 Nov;13(22):e70363. doi: 10.1002/cam4.70363.
Cancer Med. 2024.
PMID: 39552022